Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group — P. Kosmidis (2007) | RDL Network
Paclitaxel and gemcitabine versus carboplatin and gemcitabine in patients with advanced non-small-cell lung cancer. A phase III study of the Hellenic Cooperative Oncology Group
P. Kosmidis, George Fountzilas, Anastasia G Eleftheraki, Haralabos P. Kalofonos, George Pentheroudakis, Dimosthenis Skarlos, Meletios A Dimopoulos, Dimitrios Bafaloukos, Dimitrios Pectasides, E. Samantas, J. Boukovinas, Sofia Lambaki, N. Katirtzoglou, C. Bakogiannis, Konstantinos N. Syrigos
P. Kosmidis, Nick Mylonakis, C. Nicolaides, C. Kalophonos, Epaminontas Samantas, J. Boukovinas, George Fountzilas, Dimosthenis Skarlos, T. Economopoulos, D. Tsavdaridis, Pavlos Papakostas, C. Bacoyiannis, Meletios A Dimopoulos
P. Kosmidis, Eleni Timotheadou, Αngelos Koutras, George Pentheroudakis, C. Christodoulou, Meletios A Dimopoulos, D. Bafaloukos, E. Samantas, Dimitrios Pectasides, K. Syrigos
P. Kosmidis, Haralabos P. Kalofonos, K. Syrigos, D. Skarlos, George Fountzilas, C. Nicolaides, D. Bafaloukos, E. Samantas, C. Bakogiannis, Meletios A Dimopoulos
Discussion(0)
No comments yet. Be the first to comment.